![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
An elusive soluble suppressor
-
Chapter
Cytokine Cascades in HIV Infection
Since the recognition of human immunodeficiency virus type 1 (HIV-1) as the causative agent of the acquired immunodeficiency syndrome (AIDS), the search to unravel the viral and cellular factors controlling it...
-
Article
Interleukin-2 and human immunodeficiency virus infection: Pathogenic mechanisms and potential for immunologic enhancement
A hallmark of human immunodeficiency virus (HIV) infection is the progressive loss of CD4+ T lymphocytes; however, qualitative defects in immune responses occur prior to the precipitous drop CD4+ T cell number...
-
Article
Resistance to HIV–1 infection: It's in the genes
A genetic defect in the HIV-1 co-receptor provides resistance to infection.
-
Article
Host factors and the pathogenesis of HIV-induced disease
The level of human immunodeficiency virus (HIV) replication in patients reflects a balance between stimulatory and inhibitory host factors (particularly endogenous cytokines). New information concerning the ce...
-
Book
-
Chapter
Virologic and immunologic events in primary HIV infection
It is thought that a significant percentage (50-70%) of human immunodeficiency virus (HIV)-infected individuals experience a clinical syndrome of variable severity during primary infection. The symptoms are no...
-
Chapter
Introduction: Recent advances in the pathogenesis of human immunodeficiency virus infection
During the last 5 years, major advances have been made in our understanding of the pathogenesis of human immunodeficiency virus (HIV) disease and in the development of new potent antiviral agents. With regard ...
-
Chapter
Dendritic Cells Express and Use Multiple HIV Coreceptors
Dendritic cells (DC) are the first immunocompetent cells to encounter antigen at areas of inflammation in mucous membranes1, which are the major sites where the initiation of HIV infection occurs. HIV enters a mu...
-
Chapter
Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies
Lymphoid tissue is a major reservoir of human immunodeficiency virus (HIV) infection in vivo. In addition, the lymphoid microenvironment provides a replicative advantage to the virus in that it provides a mili...
-
Article
Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk
CC chemokine receptor 5 (CCR5) is a cell entry cofactor for macrophage-tropic isolates of human immunodeficiency virus-1 (HIV-1). Recently, an inactive CCR5 allele (designated here as CCR5-2) was identified th...
-
Article
Virologic and immunologic events in primary HIV infection
-
Article
Introduction: Recent advances in the pathogenesis of human immunodeficiency virus infection
-
Article
Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies
Lymphoid tissue is a major reservoir of human immunodeficiency virus (HIV) infection in vivo. In addition, the lymphoid microenvironment provides a replicative advantage to the virus in that it provides a mili...
-
Article
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) enter target cells by forming a complex between the viral envelope protein and two cell-surface membrane receptors: CD4 and a 7-span t...
-
Article
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy
Evolutionary patterns of virus replication and distribution in lymphoid tissue during the early phases of HIV infection have not been delineated. Lymph node (LN) biopsies were excised from patients at differen...
-
Article
The Role of US Government Agencies in Vaccine Research And Development
Anthony Fauci and Gregory Folkers (National Institute of Allergy and Infectious Diseases) discusses the role of US government agencies and the NIAID in particular, in the fight against infectious diseases and ...
-
Article
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
The size of the pool of resting CD4+ T cells containing replication-competent HIV in the blood of patients receiving intermittent interleukin (IL)-2 plus highly active anti-retroviral therapy (HAART) was signific...
-
Article
Re-emergence of HIV after stop** therapy
A dormant reservoir of human immuno-deficiency virus (HIV) is established early on during primary infection1 which consists of latently infected, resting CD4+ T cells carrying replication-competent HIV. This pool...
-
Article
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
We examined the pathogenic significance of the latent viral reservoir in the resting CD4+ T cell compartment of HIV-1-infected individuals as well as its involvement in the rebound of plasma viremia after discont...